Hyperuricemia Clinical Trials

155 clinical trials for Hyperuricemia across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of the Effect of Hyperuricemia on Alveolar Bone Loss — RECRUITING
• Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support Tools in the Management of Patients With "Four Highs" (Hypertension, Hyperglycemia, Hyperlipidemia, Hyperuricemia) — RECRUITING · NA
• A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease — RECRUITING · PHASE1
• A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia — RECRUITING · PHASE1
• This Study is to Estimate the Efficacy of Hemodialysis Alone for Uric Acid Clearance in Patients on Hemodialysis. In Order to Evaluate the Need of Adjuvant Uric Acid Lowering Therapy — RECRUITING
• Effects of Fibres Combined With Probiotics on Uric Acid in an ex Vivo Fermentation Model — RECRUITING
• Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia — RECRUITING
• Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia — RECRUITING · PHASE1
• CPAP Effect on Lipid Profile and Hyperuricemia in Patients With Dyslipidemia and Moderate-severe Obstructive Sleep Apnea — RECRUITING · PHASE4
• Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases — RECRUITING
• Rasburicase in Tumor Lysis Syndrome — OTHER · PHASE4
• Uric Acid Lowering Trial in Youth Onset T2D — COMPLETED · PHASE2
• Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia — COMPLETED · PHASE1
• Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) — COMPLETED · PHASE3
• Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) — ACTIVE_NOT_RECRUITING · PHASE3
• Chronic Kidney Disease and Metabolic Disorders in the Elderly — NOT_YET_RECRUITING
• Treat-to-target by Email During Urate-lowering Therapy in Gout — ACTIVE_NOT_RECRUITING · NA
• A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia — COMPLETED · PHASE2
• Effectiveness of Digital Health Intervention on Community Health Care in Middle-aged and Older Population in Taiwan — COMPLETED · NA
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — COMPLETED · PHASE3
• Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients — NOT_YET_RECRUITING
• Imagery as Biomarker of Gout — ACTIVE_NOT_RECRUITING · NA
• Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine Oxidase — COMPLETED · NA
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — COMPLETED · PHASE3
• Relationship Between Intestinal Flora Changes and Hyperuricemia Under Chronic Psychological Stress — COMPLETED
• The Effect of Exercise at Different Time Intervals on Hyperuricemia — COMPLETED · NA
• A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout Subjects — COMPLETED · PHASE2
• Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout — COMPLETED · PHASE2
• Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia — ACTIVE_NOT_RECRUITING · PHASE2
• Effect of Increased Daily Water Intake in Patients With Hyperuricemia — COMPLETED · NA
• PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function — ACTIVE_NOT_RECRUITING · PHASE1
• Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia — COMPLETED · PHASE4
• SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects — COMPLETED · PHASE1
• Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia - Results From Real-life Clinical Studies — COMPLETED
• Quercetin as Possible Supportive Therapy for Mild to Moderate Hyperuricemia — COMPLETED · NA
• Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients — COMPLETED · PHASE2
• Vegan Diet, Amla Fruits and Uric Acid — COMPLETED · NA
• Screening and Management of Hyperuricemia in Patients with Chronic Medical Diseases in Assiut University Hospital — NOT_YET_RECRUITING
• Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia — ACTIVE_NOT_RECRUITING · PHASE2
• A Safety and Tolerability Study of FCN-207 in Healthy Volunteers — COMPLETED · PHASE1
• Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects — COMPLETED · PHASE1
• Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects — COMPLETED · PHASE1
• Effect of Tigulixostat on the Pharmacokinetics of Theophylline — COMPLETED · PHASE1
• Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation — OTHER
• The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia — OTHER · NA
• Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C) — COMPLETED · NA
• Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients — COMPLETED · PHASE4
• Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial — OTHER · NA
• Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid — COMPLETED · PHASE2

Refine this search